Introduction: Adenocarcinoma of the third part of the duodenum is a rare type of tumor that has challenges in its diagnosis and management. Segmental resection with pancreatic sparing is a safe and accepted choice for the surgical intervention of this type of cancer. Case Presentation: A 33-year-old male presented with a 3-week history of symptoms of gastric outlet obstruction with anemia and weight loss. Upon investigating the patient with computed tomography and esophagogastroduodenoscopy, he was found to have an adenocarcinoma that involved the third part of the duodenum. The patient underwent segmental resection of the third and fourth part of the duodenum with pancreatic sparing. He had a smooth postoperative course. The pathological evaluation shows a 3 cm moderately differentiated adenocarcinoma with free margins. Six out of thirteen lymph nodes were having metastasis. The patient developed a soft tissue recurrence 18 months after the operation. Take-away Lessons: Adenocarcinoma of the third part of the duodenum should be kept in mind in any patient presented with symptoms of gastric outlet obstruction. It can be managed safely with segmental resection avoiding the morbidity of resection of the pancreas. Keywords: Adenocarcinoma of the small bowel, third part of the duodenum, segmental resection Note: This case report is prepared using the CARE Checklist (2013) of information to include when writing a case report (https://www.care-statement.org). The CARE guidelines for case reports help reduce bias, increase transparency, and provide early signals of what works, for which patients, and under which circumstance.
Introduction
Small bowel cancer is one of the rare types of cancer as its incidence accounts for less than 1% of all other types of cancer in the United States (1) . Moreover, it accounts only for about 2.3% of cancers of the digestive system. Duodenum is the most affected part of the small bowel with cancer (2) . However, cancer involving the third or fourth part of the duodenum has its unique challenges in its diagnosis and management due to its complex anatomical location (3) . We reported this rare case of a young male with adenocarcinoma in the third part of the duodenum and reviewed the relative literature.
Case Presentation

History and physical examination
A 33-year-old male, who is not known to have any chronic medical illness, was presented to the emergency room complaining of recurrent epigastric discomfort and postprandial vomiting for 3 weeks duration. The patient also gave a history of unintentional weight loss over three months prior to his presentation. The patient denies any history of fever, change of bowel habits, or jaundice. He was a heavy smoker (2 packs per day for about 10 years, but he quit smoking 3 years prior to his presentation). He denied any gastrointestinal malignancies in his family. Physical examination revealed a cachexic and pale young male with body mass index of 19.3 kg/m 2 (Weight = 55 kg, height = 1.69 m). He was maintaining normal vital signs. His abdominal examination was unremarkable.
Laboratory and imaging investigation
The patient's initial blood laboratory investigations were unremarkable except for a low hemoglobin level of 10 g/dl. Carcinoembryonic antigen and carbohydrate antigen were in normal range. CT scan of the chest, abdomen, and pelvis revealed the presence of a circumferential 2 cm mass involving the third part of the duodenum that is abutting the superior mesenteric artery without significant lymph-nodes enlargement ( Figure 1 ). There was no evidence of distant metastasis. Esophagogastroduodenoscopy identified an ulcerative lesion in the third part of the duodenum ( Figure 2 ). Histopathological examination of the biopsy specimen from that lesion revealed a moderately differentiated adenocarcinoma.
Treatment and outcomes
The patient underwent segmental resection of the third and fourth part of the duodenum with sparing of the pancreas. Reconstruction was made using Roux-en-Y duodenojejunostomy. The patient tolerated the procedure well and had a smooth postoperative course with no immediate or late postoperative complication. Histopathological evaluation of the resected specimen revealed a moderately differentiated adenocarcinoma of the duodenum of a 3.5 cm in size. Six out of thirteen lymph nodes were found to be positive for malignancy and all the surgical margins were free from malignancy ( Figure 3) . The malignancy was staged as T3N2M0. The patient had a smooth postoperative course and was discharged home on 6 th day post-operatively in good condition. One month later, the patient went under adjuvant chemotherapy in the form of cisplatinum and capcitabine. However, only three cycles of treatment was given since patient declined continuation of chemotherapy and opted for alternative medicine. 
Follow-up
The patient was on regular follow up with an oncology clinic and hepatobiliary and pancreatic surgery clinic with an annual computed tomography scan. After two years of follow-up, the patient was discovered to have a soft tissue mass on the computed tomography. Its size was 2×4.5×3cm and was located over the surgical bed. This mass was avid in the positron emission tomography-computed tomography (PET/CT) scan indicating a local recurrence. A tumor board was conducted with a recommendation of giving 12 cycles of concurrent chemo-radiotherapy of FOLFIRINOX regimen with no need for another surgical intervention. The patient received the therapy with a good response. Repeated PET/CT scan one year later revealed remaining of that soft tissue recurrence. Since the patient was asymptomatic, no further management was required. Figure 3 . Microscopic image of a) the moderately differentiated adenocarcinoma invading through the muscularis propria b) the tumor reaching the pericolic fat
Figure 2. Esophagogastroduodenoscopy image of the ulcerative lesion in the duodenum
Discussion
There are various histological types of small bowel cancer in which adenocarcinoma constitute about 36.9% of them. Other types are carcinoid (37.4%), stromal tumors (8.4%), and lymphomas (17.3%) (4) . In an analytic study of small bowel adenocarcinoma, duodenum was the most commonly affected part (57%) followed by jejunum (29%) and ileum (10%) (5). Furthermore, duodenal adenocarcinoma is less common in the third part than in the second part of the duodenum (6) . Patients with cancer in the third or fourth part of the duodenum usually presented after their third decade of life with symptoms of gastric outlet obstruction, anemia, and weight loss (3, 7) . Our case presented with these symptoms in younger age (33 years old). The diagnosis of cancer of the third or fourth part of the duodenum remains challenging. In a series of 47 patients with adenocarcinoma of the third or fourth segment of the duodenum reported by Tocchi A et al. (7), the tumor was diagnosed barium swallow test of the gastrointestinal tract (80.9%) while upper gastrointestinal endoscopy had a 36% false negative result as the study was terminated before reaching the site of the lesion. Therefore, a high index of suspicion is warranted to establish the diagnosis in these cases.
The decision to treat this type of tumor with segmental resection with sparing of the pancreas or with pancreaticoduodenectomy is still controversial. Compared to pancreaticoduodenectomy, segmental resection of the tumor is considered to be safe and effective with no impact on survival (8, 9) . Also, segmental resection is associated with a negligible rate of morbidity and mortality, while allowing for satisfactory margin clearance and adequate lymphadenectomy (7). Our patient underwent segmental resection of the tumor that achieved reaching free margins in all sites around the tumor. Moreover, he had a smooth postoperative course.
The role of adjuvant therapy in improving the overall survival remains unclear (5) . In a meta-analysis of 15 studies of the role of adjuvant therapy in the management of small bowel adenocarcinoma, adjuvant therapy did not show a significant survival benefit (10) . Several studies focused on the prognostic factors affecting the survival of patients with duodenal adenocarcinoma. Performing a curative surgery, lymph node metastasis, and tumor stage were common significant prognostic factors in these studies (6, 11, 12) . Moreover, patients with more than three lymph nodes positive for metastasis had significantly reduced overall survival (13) . The estimated 5-year survival rates reach 46.4% after curative surgery (12) . In our patient, six out of thirteen lymph nodes were positive for metastasis. This may contribute to his development of soft tissue recurrence two years after the operation.
Conclusions
Adenocarcinoma of the third part of the duodenum is a rare malignancy that has its challenges in the diagnosis and management. Segmental resection is a safe and preferred surgical management for these cancers. Curative surgery and lymph node metastasis are the main factors affecting the overall survival of the patients.
